| 中文名 | JNJ-31020028 |
|---|---|
| 英文名 | N-[4-[4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl]-3-fluorophenyl]-2-pyridin-3-ylbenzamide |
| 中文别名 |
JNJ-31020028游离态
抑制剂JNJ-31020028 N-(4-(4-(2-(二乙氨基)-2-氧代-1-苯乙基)哌嗪-1-基)-3-氟苯基)-2-(吡啶-3-基)苯甲酰胺 |
| 英文别名 |
4-[1-(BENZENESULFONYL)-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRROLO[2,3-B]PYRIDIN-2-YL]BENZALDEHYDE
N-(4-{4-[2-(Diethylamino)-2-oxo-1-phenylethyl]-1-piperazinyl}-3-fluorophenyl)-2-(3-pyridinyl)benzamide JNJ-31020028;JNJ JNJ 31020028 ,S6416 JNJ-31020028 1-Piperazineacetamide, N,N-diethyl-4-[2-fluoro-4-[[2-(3-pyridinyl)benzoyl]amino]phenyl]-α-phenyl N,N-Diethyl-4-[2-fluoro-4-[[2-(3-pyridinyl)benzoyl]amino]phenyl]-alpha-phenyl-1-piperazineacetamide N-(4-(4-(2-(diethylamino)-2-oxo-1-phenylethyl)piperazin-1-yl)-3-fluorophenyl)-2-(pyridin-3-yl)benzamide UNII:73F8XED6YP unii-73f8xed6yp hypothalamus,JNJ-31020028,anxiety,microdialysis,dression,JNJ31020028,norinhrine,NPY rector,Neuroptide Y Rector,Inhibitor,stress-induced anorexia,inhibit JNJ 31020028 JNJ31020028 |
| 描述 | JNJ-31020028是神经肽Y2受体选择性可脑渗透抑制剂,对人Y2和鼠源Y2受体pIC50值分别为8.07和8.22,对人源Y1、Y4和Y5受体抑制作用要弱100倍以上。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 677.5±55.0 °C at 760 mmHg |
| 分子式 | C34H36FN5O2 |
| 分子量 | 565.680 |
| 闪点 | 363.5±31.5 °C |
| 精确质量 | 565.285278 |
| PSA | 72.27000 |
| LogP | 5.23 |
| 外观性状 | white solid |
| 蒸汽压 | 0.0±2.1 mmHg at 25°C |
| 折射率 | 1.628 |
| 储存条件 | -20℃ |
|
~%
1094873-14-9 |
| 文献:JANSSEN PHARMACEUTICA, N.V. Patent: WO2009/6185 A1, 2009 ; Location in patent: Page/Page column 35-36 ; WO 2009/006185 A1 |
| 上游产品 1 | |
|---|---|
| 下游产品 0 | |